NCT01474278 A Study of RO5028442 in Adult Male High-Functioning Autistic Patients Status COMPLETED Phase PHASE1
NCT01474239 A Study of Avastin (Bevacizumab) And Fotemustine in Patients With Recurrent Glioblastoma Status COMPLETED Phase PHASE2
NCT01470716 Neoadjuvant Erlotinib for Operable Stage II or IIIA NSCLC With EGFR Mutations Status UNKNOWN Phase PHASE2
NCT01468077 A Study in Patients With Moderate to Severe Active Rheumatoid Arthritis Comparing Different Infusion Durations of RoActemra/Actemra (Tocilizumab) Treatment Status COMPLETED Phase PHASE2
NCT01462175 A First-In-Human Study of RO5503781 in Participants With Advanced Malignancies Except Leukemia Status COMPLETED Phase PHASE1
NCT01462162 A Prospective Observational Study of Tocilizumab (RoActemra/Actemra) in Participants With Rheumatoid Arthritis Status COMPLETED Phase N/A
NCT01461967 A Study on Safety, Pharmacokinetics and Pharmacodynamics of RO5508887 in Healthy Volunteers Status COMPLETED Phase PHASE1
NCT01461928 A Study Comparing Maintenance Subcutaneous Rituximab With Observation Only in Participants With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma Who Had Responded to Rituximab-based Immunochemotherapy Induction and 2-year Maintenance With Subcutaneous Rituximab Status COMPLETED Phase PHASE3
NCT01461057 A Study of Pertuzumab in Combination With Trastuzumab and Chemotherapy in Patients With HER2-Positive Advanced Gastric Cancer Status COMPLETED Phase PHASE2
NCT01461044 An Observational Study of Avastin (Bevacizumab) in Patients With HER2-metastatic or Locally Advanced Breast Cancer Status COMPLETED Phase N/A
NCT01460446 ACCU-CHEK® Aviva Expert Study: Does Use of a Bolus Advisor Improve Glycemic Control in Patients Not Achieving Optimal Control Using Multiple Daily Injections (MDI)? Status COMPLETED Phase NA
NCT01457677 ARTDeCo Study: A Study of RO4995819 in Patients With Major Depressive Disorder And Inadequate Response to Ongoing Antidepressant Treatment Status COMPLETED Phase PHASE2
NCT01456325 A Study of Onartuzumab (MetMAb) in Combination With Tarceva (Erlotinib) in Participants With Met Diagnostic-Positive Non-Small Cell Lung Cancer Who Have Received Chemotherapy For Advanced or Metastatic Disease (MetLung) Status COMPLETED Phase PHASE3
NCT01456234 Time to Oseltamivir Access When Prescribed by Pharmacists Versus Physicians (ACCESS) Status TERMINATED Phase PHASE4
NCT01455701 A Study to Evaluate Pharmacokinetics and Safety of Tocilizumab (RoActemra/Actemra) in Participants Less Than 2 Years Old With Active Systemic Juvenile Idiopathic Arthritis (sJIA) Status COMPLETED Phase PHASE1
NCT01450878 Renal Graft Function After Treatment With Erythropoietin (EPO) Status TERMINATED Phase PHASE3
NCT01450696 A Study of Herceptin (Trastuzumab) in Combination With Cisplatin/Capecitabine Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Gastric or Gastro-Esophageal Junction Cancer Status TERMINATED Phase PHASE3
NCT01447446 An Observational Study on Dual And Triple Therapies Based on Peginterferon Alfa (e.g. Pegasys) in Patients With Chronic Hepatitis C Status COMPLETED Phase N/A
NCT01447420 A Study of Sustained Virological Response in Relation to IL28-b Expression in Treatment-Naïve Patients With Chronic Hepatitis C Genotype 1 on Combination Treatment With Pegasys (Peginterferon Alfa-2a) and Copegus (Ribavirin) Status COMPLETED Phase PHASE4